Litigation

Recent Posts

Supreme Court: Can Generic Drug Maker Be Sued Over Labels?
Posted on 31 Mar 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court seemed split on Wednesday on whether to allow generic drug makers to be sued in state court for not trying to get federal regulators to add warnings about potentially dangerous side effects to their drug labels... Read More

U.S. Supreme Court To Decide Whether Claims About Generic Drugs Are Preempted
Posted on 13 Dec 2010 by Tom Moylan

WASHINGTON, D.C. -- (Mealey's) The U.S. Supreme Court on Dec. 10 agreed to decide whether the Hatch Waxman Act prevents manufacturers of generic drugs from adding new warnings to drug labels as new risks become known ( Pliva, Inc. v. Gladys Mensing... Read More